Maya Ghoussaini

Cambridge, ENG CB18RN, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

A genomic-led strategy to anticipate drug safety effects.

A genomic-led strategy to anticipate drug safety effects.

Journal: PLoS genetics

Published: September 30, 2025

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Journal: Nature communications

Published: September 09, 2025

Variant Classification Using Proteomics-Informed Large Language Models Increases Power of Rare Variant Association Studies and Enhances Target Discovery.

Variant Classification Using Proteomics-Informed Large Language Models Increases Power of Rare Variant Association Studies and Enhances Target Discovery.

Journal: Genetic epidemiology

Published: April 28, 2025

Leveraging large-scale biobanks for therapeutic target discovery.

Leveraging large-scale biobanks for therapeutic target discovery.

Journal: HGG advances

Published: April 17, 2025

Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery.

Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery.

Journal: Nucleic acids research

Published: September 13, 2024

Future prospects for human genetics and genomics in drug discovery.

Future prospects for human genetics and genomics in drug discovery.

Journal: Current opinion in structural biology

Published: September 30, 2022

The next-generation Open Targets Platform: reimagined, redesigned, rebuilt.

The next-generation Open Targets Platform: reimagined, redesigned, rebuilt.

Journal: Nucleic acids research

Published: September 15, 2022

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

Journal: Nature genetics

Published: August 21, 2022

Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs.

Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs.

Journal: Nature reviews. Drug discovery

Published: July 08, 2022

Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity.

Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity.

Journal: EBioMedicine

Published: March 08, 2022

Mapping interindividual dynamics of innate immune response at single-cell resolution.

Mapping interindividual dynamics of innate immune response at single-cell resolution.

Journal: Nature genetics

Published: August 28, 2021

Network expansion of genetic associations defines a pleiotropy map of human cell biology.

Network expansion of genetic associations defines a pleiotropy map of human cell biology.

Journal: Nature genetics

Published: July 19, 2021

Showing 1-12 of 49

Last Updated: 09/26/2026